Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nephros ( (NEPH) ) has provided an announcement.
On February 26, 2025, Nephros, Inc. amended the employment terms of its Chief Financial Officer, Judith Krandel. The amendment grants Ms. Krandel two 10-year stock options under the company’s 2024 Equity Incentive Plan, with specific vesting conditions tied to her continued employment and the company’s strategic transactions. Additionally, her annual performance bonus target is increased to 30% of her base salary. This amendment could potentially strengthen the company’s leadership stability and incentivize growth-oriented strategies.
More about Nephros
YTD Price Performance: 3.42%
Average Trading Volume: 12,602
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $15.92M
See more insights into NEPH stock on TipRanks’ Stock Analysis page.